Understanding of trisomy 21 prenatal screening among pregnant women in France: A cross-sectional study in light of 2019 guidelines
Although most women received information from a healthcare professional, both their perceived and actual comprehension of trisomy 21 screening, especially regarding cfDNA screening test, remained limited. These findings highlight the need for improved communication tools and tailored support to ensure informed decision-making across diverse populations.
Authors
- N. Sananès (ORCID: https://orcid.org/0000-0002-0461-8428)
- Eva Van Steijvoort (ORCID: https://orcid.org/0000-0003-3134-4028)
- P. Rodrigues
- Romain Demailly (ORCID: https://orcid.org/0000-0003-1711-236X)
- Clément Wulveryck
Institutions
- Hôpital américain de paris (FR)
- Université Catholique de Lille (FR)
- KU Leuven (BE)
Publication Details
- Journal
- Journal of Gynecology Obstetrics and Human Reproduction
- Published
- 2026-01-12
- DOI
- https://doi.org/10.1016/j.jogoh.2026.103109
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00